Qentoros
The startup develops biological therapeutics using platelet-rich plasma (PRP) formulations to treat infectious and inflammatory conditions in both animals and humans. This approach enhances immune response, reduces excessive inflammation, and promotes tissue regeneration.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$20KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biological therapeutics using platelet-rich plasma (PRP) formulations to treat infectious and inflammatory conditions in both animals and humans. This approach enhances immune response, reduces excessive inflammation, and promotes tissue regeneration.